Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Grazoprevir + Elbasvir for Acute HCV Genotype 1/4 in HIV Patients
NCT02600325Phase 3Completed
- Sponsor
- Erasmus MC
- Start
- Feb 2016
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of grazoprevir in hepatitis C virus infection, sponsored by Erasmus MC. Started Feb 2016; status: completed.
02
Drugs
grazoprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT02600325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02600325.